$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

$tsoi Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223040890 Filed on November 14, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$23.83K	$25.73K	$74.54K
YoY Change	177.74%	-65.48%	30.11%
Cost Of Revenue	$10.55K	$7.052K	$8.790K
YoY Change	-77.07%	-19.77%	-29.28%
Gross Profit	$13.28K	$18.68K	$65.75K
YoY Change	-135.49%	-71.59%	46.57%
Gross Profit Margin	55.73%	72.59%	88.21%
Selling, General & Admin	$419.6K	$330.0K	$509.9K
YoY Change	-8.23%	-35.28%	-28.69%
% of Gross Profit	3159.26%	1766.78%	775.5%
Research & Development	$150.5K	$148.9K	$275.1K
YoY Change	-42.99%	-45.88%	764.46%
% of Gross Profit	1133.36%	797.08%	418.35%
Depreciation & Amortization	$81.78K	$70.00K	$87.54K
YoY Change	63.69%	-20.04%	1907.8%
% of Gross Profit	615.81%	374.77%	133.14%
Operating Expenses	$570.1K	$476.0K	$785.0K
YoY Change	-20.96%	-39.36%	5.1%
Operating Profit	-$556.8K	-$457.3K	-$719.2K
YoY Change	-26.61%	-36.41%	2.45%
Interest Expense	-$5.080K	$83.06K	$167.4K
YoY Change	-92.78%	-50.37%	-248.39%
% of Operating Profit
Other Income/Expense, Net		-$145.5K	-$226.4K
YoY Change		-35.74%
Pretax Income	-$479.3K	-$602.9K	-$945.7K
YoY Change	-49.0%	-36.25%	16.06%
Income Tax	$1.450K		$800.00
% Of Pretax Income
Net Earnings	-$427.5K	-$602.0K	-$946.5K
YoY Change	-54.51%	-36.39%	16.16%
Net Earnings / Revenue	-1793.92%	-2339.84%	-1269.72%
Basic Earnings Per Share		$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$368.90
COMMON SHARES
Basic Shares Outstanding	3.736B shares	332.5M shares	2.566B shares
Diluted Shares Outstanding		3.287B shares	2.566B shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$27.82K	$90.00K	$94.25K
YoY Change	54.21%	-4.51%	51.38%
Cash & Equivalents	$27.82K	$90.14K	$94.25K
Short-Term Investments
Other Short-Term Assets	$16.32K	$40.00K	$343.0K
YoY Change	-92.69%	-88.34%	9.8%
Inventory	$22.57K	$26.42K	$44.94K
Prepaid Expenses	$11.04K	$24.12K
Receivables	$19.20K	$21.76K	$42.38K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$85.91K	$181.0K	$524.6K
YoY Change	-72.22%	-65.5%	14.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$499.9K	$377.1K	$354.1K
YoY Change	83.06%	6.48%	1.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.120K	$2.785M	$3.298M
YoY Change	-99.86%	-15.58%	1386.46%
Total Long-Term Assets	$3.206M	$3.293M	$3.668M
YoY Change	-2.74%	-10.2%	418.24%
TOTAL ASSETS
Total Short-Term Assets	$85.91K	$181.0K	$524.6K
Total Long-Term Assets	$3.206M	$3.293M	$3.668M
Total Assets	$3.292M	$3.474M	$4.192M
YoY Change	-8.7%	-17.12%	259.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$404.9K	$380.0K	$364.0K
YoY Change	0.72%	4.4%	0.64%
Accrued Expenses	$556.6K	$601.4K	$552.2K
YoY Change	4.67%	8.91%	16.15%
Deferred Revenue
YoY Change
Short-Term Debt	$752.4K	$750.0K	$1.061M
YoY Change	-28.61%	-29.33%	-0.33%
Long-Term Debt Due	$4.640K	$0.00	$4.640K
YoY Change	0.0%	-100.0%	14.0%
Total Short-Term Liabilities	$1.900M	$2.053M	$2.395M
YoY Change	-14.05%	-14.26%	6.19%
LONG-TERM LIABILITIES
Long-Term Debt	$5.510K	$10.00K	$11.64K
YoY Change	-47.57%	-14.09%	-30.01%
Other Long-Term Liabilities	$105.0K	$110.0K	$2.150K
YoY Change		5016.28%	-85.73%
Total Long-Term Liabilities	$110.5K	$120.0K	$13.79K
YoY Change	951.76%	770.2%	-56.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.900M	$2.053M	$2.395M
Total Long-Term Liabilities	$110.5K	$120.0K	$13.79K
Total Liabilities	$2.167M	$2.165M	$2.409M
YoY Change	-2.43%	-10.11%	5.32%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.33M	-$19.41M	-$16.73M
YoY Change	15.02%	16.03%
Common Stock	$3.803M	$3.451M	$2.588M
YoY Change	45.28%	33.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.125M	$1.311M	$1.784M
YoY Change
Total Liabilities & Shareholders Equity	$3.292M	$3.474M	$4.192M
YoY Change	-8.7%	-17.12%	259.77%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$427.5K	-$602.0K	-$946.5K
YoY Change	-54.51%	-36.39%	16.16%
Depreciation, Depletion And Amortization	$81.78K	$70.00K	$87.54K
YoY Change	63.69%	-20.04%	1907.8%
Cash From Operating Activities	-$205.3K	-$310.0K	-$201.9K
YoY Change	-43.77%	53.55%	58.71%
INVESTING ACTIVITIES
Capital Expenditures	-$3.840K	$20.00K	$0.00
YoY Change	-98.08%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$7.840K	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$4.000K	-$20.00K	$0.00
YoY Change	-102.0%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	147.7K	300.0K	98.85K
YoY Change	66.19%	203.49%	-37.78%
NET CHANGE
Cash From Operating Activities	-205.3K	-310.0K	-201.9K
Cash From Investing Activities	-4.000K	-20.00K	0.000
Cash From Financing Activities	147.7K	300.0K	98.85K
Net Change In Cash	-61.61K	-30.00K	-103.0K
YoY Change	-19.15%	-70.89%	-1316.53%
FREE CASH FLOW
Cash From Operating Activities	-$205.3K	-$310.0K	-$201.9K
Capital Expenditures	-$3.840K	$20.00K	$0.00
Free Cash Flow	-$201.5K	-$330.0K	-$201.9K
YoY Change	22.05%	63.46%	94.11%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001419051
CY2023Q3	us-gaap	Restricted Cash RestrictedCash		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		usd
CY2023Q3	TSOI	Stock Issued During Period Value For Prepaid Fees StockIssuedDuringPeriodValueForPrepaidFees		usd
CY2023Q3	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries		usd
CY2023Q3	TSOI	Adjustments To Additional Paid In Capital Subsidiary For Services AdjustmentsToAdditionalPaidInCapitalSubsidiaryForServices		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	TSOI	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	TSOI	Common Stock Issued For License Value CommonStockIssuedForLicenseValue		usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability		usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash		usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	211919728	shares
CY2023Q3	TSOI	Prepaid Consulting Noncurrent PrepaidConsultingNoncurrent		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54554
	dei	Entity Registrant Name EntityRegistrantName	Therapeutic Solutions International, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-1226465
	dei	Entity Address Address Line1 EntityAddressAddressLine1	701 Wild Rose Lane
	dei	Entity Address City Or Town EntityAddressCityOrTown	Elk City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83525
	dei	City Area Code CityAreaCode	(760)
	dei	Local Phone Number LocalPhoneNumber	295-7208
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3736449424	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90138	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18040	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	11003	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21764	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	25398	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	26418	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	42428	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42661	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	212352	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	180981	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	309221	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	377076	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273078	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	131818	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8612	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2784502	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3014620	usd
CY2023Q3	us-gaap	Assets Assets	3474377	usd
CY2022Q4	us-gaap	Assets Assets	3605531	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	601446	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	531783	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	26786	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8612	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	157861	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	175063	usd
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	46139	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	65187	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	292699	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	202144	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2053239	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2210237	usd
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	6810	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	10507	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	105032	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2165081	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2220744	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5500000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3450665355	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3450665355	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2617390830	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2617390830	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	3450666	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2617392	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17282608	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16334129	usd
CY2023Q3	TSOI	Shares To Be Issued SharesToBeIssued	13074	usd
CY2022Q4	TSOI	Shares To Be Issued SharesToBeIssued	126324	usd
CY2023Q3	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	21000	usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	21000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-19414380	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17672058	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1310968	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1384787	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-1672	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1309296	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1384787	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3474377	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3605531	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25730	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74541	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75161	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	198188	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7052	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8790	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26217	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33437	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	18678	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	65751	usd
	us-gaap	Gross Profit GrossProfit	48944	usd
	us-gaap	Gross Profit GrossProfit	164751	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	127204	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	204838	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	359948	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	388561	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	111220	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	110108	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	335699	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	336926	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	20150	usd
CY2022Q3	us-gaap	Professional Fees ProfessionalFees	88158	usd
	us-gaap	Professional Fees ProfessionalFees	142907	usd
	us-gaap	Professional Fees ProfessionalFees	317284	usd
CY2023Q3	us-gaap	Legal Fees LegalFees	68560	usd
CY2022Q3	us-gaap	Legal Fees LegalFees	106795	usd
	us-gaap	Legal Fees LegalFees	229952	usd
	us-gaap	Legal Fees LegalFees	266158	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	148879	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	275071	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	410146	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1177123	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	476013	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	784970	usd
	us-gaap	Operating Expenses OperatingExpenses	1478652	usd
	us-gaap	Operating Expenses OperatingExpenses	2486052	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-457335	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-719219	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1429708	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2321301	usd
CY2023Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2336	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-26867	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	21939	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-136583	usd
CY2023Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-60124	usd
CY2022Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-32205	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-93836	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	233303	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	83062	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	167371	usd
	us-gaap	Interest Expense InterestExpense	327135	usd
	us-gaap	Interest Expense InterestExpense	512761	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	85546	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-145522	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-226443	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-313486	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-416041	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-602857	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-945662	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1743194	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2737342	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-602857	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-946462	usd
	us-gaap	Profit Loss ProfitLoss	-1743994	usd
	us-gaap	Profit Loss ProfitLoss	-2738142	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-816	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1672	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-602041	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-946462	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1742322	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2738142	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3286909395	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3286909395	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2565663048	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2565663048	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2987459958	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2987459958	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2501116667	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2501116667	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-804982	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	508078	usd
	TSOI	Stock Issued During Period Value For Prepaid Fees StockIssuedDuringPeriodValueForPrepaidFees	242320	usd
	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	29999	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	445000	usd
	TSOI	Stock Issued During Period Value For License StockIssuedDuringPeriodValueForLicense	3107570	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	943432	usd
	TSOI	Stock Issued During Period Common Stock Issued For Land Development StockIssuedDuringPeriodCommonStockIssuedForLandDevelopment	50400	usd
	us-gaap	Profit Loss ProfitLoss	-2738142	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1783675	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2212440	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100878	usd
CY2022Q3	TSOI	Stock Issued During Period Value For Prepaid Fees StockIssuedDuringPeriodValueForPrepaidFees	93500	usd
CY2022Q3	TSOI	Stock Issued During Period Common Stock Issued For Land Development StockIssuedDuringPeriodCommonStockIssuedForLandDevelopment	50400	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	272919	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-946462	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1783675	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1384787	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	86161	usd
	TSOI	Stock Issued During Period Values For Salaries StockIssuedDuringPeriodValuesForSalaries	20000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	677378	usd
	TSOI	Adjustments To Additional Paid In Capital Subsidiary For Services AdjustmentsToAdditionalPaidInCapitalSubsidiaryForServices	1831	usd
	TSOI	Stock Issued During Period Common Stock Issued For Land Development StockIssuedDuringPeriodCommonStockIssuedForLandDevelopment	96000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	787133	usd
	us-gaap	Profit Loss ProfitLoss	-1743994	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1309296	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1491152	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	6561	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	189026	usd
CY2023Q3	TSOI	Stock Issued During Period Common Stock Issued For Land Development StockIssuedDuringPeriodCommonStockIssuedForLandDevelopment	96000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	129414	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-602857	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1309296	usd
	us-gaap	Profit Loss ProfitLoss	-1743994	usd
	us-gaap	Profit Loss ProfitLoss	-2738142	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	311078	usd
	TSOI	Share Based Compensation To Related Parties ShareBasedCompensationToRelatedParties	86161	usd
	TSOI	Share Based Compensation To Related Parties ShareBasedCompensationToRelatedParties	197000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	21939	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-136583	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-93836	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	233303	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	85546	usd
	TSOI	Amortization Of Prepaid Stock Based Compensation AmortizationOfPrepaidStockBasedCompensation	112971	usd
	TSOI	Amortization Of Prepaid Stock Based Compensation AmortizationOfPrepaidStockBasedCompensation	868089	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	299267	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	461058	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	222581	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	191192	usd
	us-gaap	Depreciation Depreciation	8161	usd
	us-gaap	Depreciation Depreciation	3489	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3634	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	25769	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-16010	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5126	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-69595	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-73807	usd
	TSOI	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	23038	usd
	TSOI	Increase Decrease In Right Of Use Asset IncreaseDecreaseInRightOfUseAsset	19113	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27535	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30051	usd
	TSOI	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	-3	usd
	TSOI	Increase Decrease In Account Payable Related Parties IncreaseDecreaseInAccountPayableRelatedParties	-2552	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	117538	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	139405	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-23038	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-19113	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-849263	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-653242	usd
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	16158	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	200000	usd
	TSOI	Payments For Proceeds From Notes Receivable PaymentsForProceedsFromNotesReceivable	3507	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19665	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-200000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	17	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2444	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	5609	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	250750	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	415000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3697	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3324	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	677378	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	445000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	930023	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	854232	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	61095	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	990	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	29043	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	104259	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	90138	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	105249	usd
	us-gaap	Interest Paid Net InterestPaidNet	2475	usd
	us-gaap	Interest Paid Net InterestPaidNet	2357	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	800	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	32500	usd
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	30500	usd
	TSOI	Debt Discount Recorded In Connection With Derivative Liability DebtDiscountRecordedInConnectionWithDerivativeLiability	249565	usd
	TSOI	Debt Discount Recorded In Connection With Derivative Liability DebtDiscountRecordedInConnectionWithDerivativeLiability	415000	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	787133	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	943431	usd
	TSOI	Common Stock Issued For Prepaid Fees Value CommonStockIssuedForPrepaidFeesValue	1831	usd
	TSOI	Common Stock Issued For Prepaid Fees Value CommonStockIssuedForPrepaidFeesValue	242320	usd
	TSOI	Common Stock Issued For Accrued Salaries Value CommonStockIssuedForAccruedSalariesValue	20000	usd
	TSOI	Common Stock Issued For Accrued Salaries Value CommonStockIssuedForAccruedSalariesValue	29999	usd
	TSOI	Accrued Interest Added To Principal AccruedInterestAddedToPrincipal	11148	usd
	TSOI	Accrued Interest Added To Principal AccruedInterestAddedToPrincipal	19436	usd
	TSOI	Common Stock Issued For License Value CommonStockIssuedForLicenseValue	3107570	usd
	TSOI	Common Stock Issued For Land Development CommonStockIssuedForLandDevelopment	96000	usd
	TSOI	Common Stock Issued For Land Development CommonStockIssuedForLandDevelopment	50400	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	146244	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	90138	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94246	usd
CY2022Q3	us-gaap	Restricted Cash RestrictedCash	11003	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	90138	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105249	usd
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2007-08-06
	us-gaap	Net Income Loss NetIncomeLoss	-19400000	usd
	TSOI	Wholesale Purchase Price And Payments Description WholesalePurchasePriceAndPaymentsDescription	Seller agrees to sell the Goods to Buyer for Fifty Percent (50%) off Sellers listed retail price (see Exhibit A). Seller will provide an invoice to Buyer at the time of delivery. All invoices must be paid, in full, within thirty (30) days. Any balances not paid within thirty (30) days will be subject to a five percent (5%) late payment penalty. In the event Buyer exceeds the aggregate of $500,000 worth of aforementioned products having been purchased, delivered, and paid for, Buyer will be entitled to an additional Five Percent (5%) discount up to the aggregate of $750,000.00. In the event Buyer exceeds the aggregate of $750,000 worth of aforementioned products having been purchased, delivered, and paid for, Buyer will be entitled to an additional Five Percent (5%) discount up to the aggregate of $1,500,000.00. All future sales after initial $1,500,000 in aggregate purchases will be sold at 60% off retail.
CY2023Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	292699	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	202144	usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	202144	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues	328433	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet	-331714	usd
	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Period Increase Decrease FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease	93836	usd
CY2023Q3	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs	292699	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_z3Z8roybI6Df" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_z0supbcLzBrf">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimates were made relating to valuation allowances, impairment of assets, share-based compensation expense and accruals. Actual results could differ materially from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	212352	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1259591300	shares
	us-gaap	Depreciation Depreciation	8161	usd
	us-gaap	Depreciation Depreciation	3489	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	222581	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	191192	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	410146	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1177123	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	131818	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	131818	usd
CY2023Q3	TSOI	Prepaid Consulting Current PrepaidConsultingCurrent	16939	usd
CY2022Q4	TSOI	Prepaid Consulting Current PrepaidConsultingCurrent	148550	usd
CY2023Q3	us-gaap	Prepaid Insurance PrepaidInsurance	1601	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1141	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	24121	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	62661	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42661	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	413517	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	301359	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36441	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	28281	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	377076	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	273078	usd
	us-gaap	Depreciation Depreciation	8161	usd
	us-gaap	Depreciation Depreciation	3489	usd
CY2022Q4	TSOI	Prepaid Consulting Noncurrent PrepaidConsultingNoncurrent	7537	usd
CY2023Q3	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4123	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	4123	usd
CY2023Q3	TSOI	Licenses Noncurrent LicensesNoncurrent	2780379	usd
CY2022Q4	TSOI	Licenses Noncurrent LicensesNoncurrent	3002960	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2784502	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3014620	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3261122	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3261122	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	480743	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	258162	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2780379	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3002960	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	222581	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	191192	usd
CY2023Q3	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	5505000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3450665355	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	2	shares
CY2022Q3	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	the Board of Directors designated “Series A Preferred Stock” and caused to be filed a Certificate of Designation pursuant to NRS 78.1955 with the State of Nevada, and upon approval the Board has issued One (1) share of Series A Preferred Stock to Thomas E. Ichim, and One (1) share of Series A Preferred Stock to Timothy G. Dixon. The Holder of the Series A Preferred Stock shall be entitled to vote on all matters subject to a vote or written consent of the holders of the Corporation’s Common Stock, and on all such matters, the share of Series A Preferred Stock shall be entitled to that number of votes equal to the number of votes that all issued and outstanding shares of Common Stock and all other securities of the Corporation are entitled to, as of any such date of determination, on a fully diluted basis, plus One Million (1,000,000) votes, it being the intention that the Holder(s) of the Series A Preferred Stock shall have effective voting control of the Corporation, on a fully diluted basis. The Holder(s) of the Series A Preferred Stock shall vote together with the holders of Common Stock as a single class
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	2	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Minority Interest MinorityInterest	-1672	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5500000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q1	us-gaap	Area Of Land AreaOfLand	1700	sqft
CY2023Q1	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2028-04-30
	us-gaap	Payments For Rent PaymentsForRent	18988	usd
	us-gaap	Payments For Rent PaymentsForRent	18783	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.05	pure

Files In Submission

Name	View Source	Status
0001493152-23-040890-index-headers.html	Edgar Link	pending
0001493152-23-040890-index.html	Edgar Link	pending
0001493152-23-040890.txt	Edgar Link	pending
0001493152-23-040890-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
tsoi-20230930.xsd	Edgar Link	pending
tsoi-20230930_cal.xml	Edgar Link	unprocessable
tsoi-20230930_def.xml	Edgar Link	unprocessable
tsoi-20230930_lab.xml	Edgar Link	unprocessable
tsoi-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

2023 Q4 Form 10-Q Financial Statement

#000149315223040890 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSOI THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi

2023 Q4 Form 10-Q Financial Statement

#000149315223040890 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TSOI
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Stock $tsoi